OKYO Pharma Ltd (OKYO) Institutional Shareholders
OKYO Pharma Ltd (OKYO) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $9.74M in OKYO holdings during the latest filing period.
Woodline Partners Lp is currently the largest disclosed institutional shareholder of OKYO tracked by InsiderSet, reporting ownership valued at approximately $5.48M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $4.97M, representing an estimated loss of -9.33% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 99% of the total disclosed OKYO value among the investors covered in this analysis. Major shareholders include Woodline Partners Lp, Stonepine Capital Management, Llc, Maven Securities Ltd, and several other long-term asset managers with concentrated positions in OKYO Pharma Ltd (OKYO).
This page ranks the largest institutional OKYO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
19
Total Reported Value
$9.74M
Largest Holder
Woodline Partners Lp
Largest Position
$5.48M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
21
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Woodline Partners Lp | 0.02% | 3,652,768 | $5,479,152 | $4,967,764 | -$511,388 | -9.33% | |
| Stonepine Capital Management, Llc | 0.99% | 862,996 | $1,294,494 | $1,173,675 | -$120,819 | -9.33% | |
| Maven Securities Ltd | 0.08% | 809,317 | $1,213,976 | $1,100,671 | -$113,305 | -9.33% | |
| Balyasny Asset Management L.P. | 0.00% | 580,596 | $870,894 | $789,611 | -$81,283 | -9.33% | |
| Opaleye Management Inc. | 0.05% | 375,204 | $562,806 | $510,277 | -$52,529 | -9.33% | |
| Ubs Group Ag | 0.00% | 55,009 | $82,514 | $74,812 | -$7,702 | -9.33% | |
| Xtx Topco Ltd | 0.00% | 37,769 | $56,654 | $51,366 | -$5,288 | -9.33% | |
| Choreo, Llc | 0.00% | 33,255 | $49,883 | $45,227 | -$4,656 | -9.33% | |
| Quantinno Capital Management Lp | 0.00% | 33,255 | $49,882 | $45,227 | -$4,655 | -9.33% | |
| Cerity Partners Llc | 0.00% | 12,812 | $19,218 | $17,424 | -$1,794 | -9.33% | |
| Geode Capital Management, Llc | 0.00% | 12,090 | $18,135 | $16,442 | -$1,693 | -9.33% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 11,200 | $16,800 | $15,232 | -$1,568 | -9.33% |
| Jane Street Group, Llc | 0.00% | 10,302 | $15,453 | $14,011 | -$1,442 | -9.33% | |
| Steward Partners Investment Advisory, Llc | 0.00% | 6,000 | $9,000 | $8,160 | -$840 | -9.33% | |
| Efg International Ag | 0.00% | 923 | $1,385 | $1,255 | -$130 | -9.37% | |
| Osaic Holdings, Inc. | 0.00% | 152 | $228 | $207 | -$21 | -9.33% | |
| Continuum Advisory, Llc | 0.00% | 50 | $75 | $68 | -$7 | -9.33% | |
| Morgan Stanley | 0.00% | 10 | $15 | $14 | -$1 | -9.33% | |
| Caitong International Asset Management Co., Ltd | 0.00% | 3 | $4 | $4 | +$0 | +2.00% |
Frequently asked questions about OKYO
Who owns the most OKYO stock?
The largest holders of OKYO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for OKYO Pharma Ltd (OKYO).
Is OKYO widely held by superinvestors?
Many widely followed stocks like OKYO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly OKYO is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.